Trust & Legal · Mexico

Mexico Compliance

How we operate in compliance with Mexican health-information, data-privacy, and advertising regulations — in plain language, with the citations underneath.

Last updated: 27 June 2026

In plain language

TTL is an educational health-information platform, not a clinic, pharmacy, or compounding lab. In Mexico we operate as an information service under the General Health Law (LGS), the Regulation on Advertising (RLGSMP), the Federal Data Protection Law (LFPDPPP), and the relevant Official Mexican Standards (NOMs).

We do not prescribe, dispense, or sell peptides, hormones, or any prescription medication in Mexico. Any medical decision is made by you with a licensed Mexican physician of your choice. Our peptide content in Mexico is educational only, with no purchase or intake path attached. Consult your physician (consulta a tu médico) before making any health-related decision.

1. Responsable Sanitario (Article 19 RLGSMP)

Article 19 of the General Health Law’s Regulation on Advertising (RLGSMP) requires any health-related advertising in Mexico to identify the responsible physician (responsable sanitario) and disclose their credentials. Below are TTL Mexico’s designated credentials.

Responsable Sanitario
To be announced
Cédula Profesional
To be announced
Especialidad
To be announced
Institución
To be announced
Aviso de Publicidad (DIGIPRiS)
To be announced

Filing in progress. While the Aviso is pending we limit MX-targeted advertising to educational, non-promotional content only and link to this transparency page from every public-facing surface in compliance with the Article 19 spirit.

2. Regulatory framework we operate under

  • Ley General de Salud (LGS) — Title XIII, Sole Chapter (Articles 300–310). Governs all health-related advertising in Mexico.
  • Reglamento de la Ley General de Salud en Materia de Publicidad (RLGSMP) — the implementing regulation. Article 17 (information by correspondence/web), Article 18 (prohibited service-advertising scenarios), Article 19 (credential-disclosure requirement), Article 86 (Aviso de Publicidad).
  • Ley Federal de Protección de Datos Personales en Posesión de los Particulares (LFPDPPP) — how we collect, process, and protect personal data, including sensitive health data which requires express consent. See our Aviso de Privacidad.
  • NOM-024-SSA3-2012 — standards for electronic health-record information systems (SIRES). Applies to any telehealth partner that records or exchanges clinical information; TTL itself is an information platform, not a SIRES.
  • NOM-004-SSA3-2012 — clinical-file standards. Applies to licensed clinicians and telehealth partners.
  • COFEPRIS — the Federal Commission for the Protection against Sanitary Risks. The enforcement authority for health advertising and product/service regulation.

3. What we do — and what we don’t do — in Mexico

We do

  • Provide educational health and wellness information powered by AI.
  • Generate personalized informational protocols based on the data you share.
  • Operate under express consent for sensitive health-data processing.
  • Display the medical disclaimer and “Consulta a tu médico” notice on every page.
  • Encrypt personal health information at rest and in transit.
  • Maintain a verifiable Aviso de Privacidad with INAI escalation rights.

We don’t

  • Prescribe, dispense, or sell medications, peptides, or hormones.
  • Provide medical diagnosis, treatment, or emergency care.
  • Offer peptide therapies for purchase in Mexico (peptides are educational only).
  • Make curative, miracle, or guaranteed-outcome claims.
  • Sell, rent, or trade your personal data.
  • Substitute the clinical judgment of a licensed Mexican physician.

4. Peptide content in Mexico — educational only

Most wellness peptides (BPC-157, TB-500, GHK-Cu, MOTS-c, Epitalon, Selank, Semax, KPV, and others) do not have a COFEPRIS sanitary registration (registro sanitario) and are not in the Mexican Pharmacopoeia (FEUM). COFEPRIS issued a sanitary alert in April 2026 against the unlawful sale of these compounds via social media.

For visitors in Mexico, TTL’s peptide content is provided strictly for educational and decision-support purposes. We do not offer a purchase, prescription, or intake-to-Rx path for peptides in Mexico. If you choose to discuss peptide therapy, that conversation belongs with a licensed Mexican physician of your choice, on their own clinical judgment, and within the framework of Mexican law.

FDA-approved peptide medications (semaglutide, tirzepatide, liraglutide, tesamorelin, bremelanotide/PT-141) are mentioned for educational context. They are prescription medications in Mexico (sujeto a receta médica) and any clinical decision regarding them is reserved exclusively to a licensed Mexican physician.

5. Advertising practices for Mexico-targeted content

In any advertising or content directed to Mexican audiences we commit to:

  • Filing the Aviso de Publicidad with COFEPRIS through DIGIPRiS before running paid campaigns.
  • Displaying the responsable sanitario name, cédula, especialidad, and institución on every relevant surface (per Article 19 RLGSMP).
  • Including the “Consulta a tu médico” disclaimer on audio/visual content.
  • Avoiding curative claims (“cura”, “curación definitiva”, “milagroso”), guarantee language (“garantizado”, “100% seguro”, “sin efectos secundarios”), unsubstantiated superlatives (“el mejor”, “el número uno”), and specific weight-loss promises.
  • Not directing prescription-drug brand-name advertising to the general public.
  • Not using manipulated before/after imagery, celebrity testimonials, or unsubstantiable patient testimonials.
  • Documenting and re-auditing every Mexico-targeted creative against this checklist before publication.

6. Telehealth in Mexico (when available)

Telehealth clinical services in Mexico, when offered, are delivered by independently licensed telehealth practices — not by TTL. The partner practice is responsible for:

  • Filing its own Aviso de Funcionamiento with COFEPRIS as a health-services establishment.
  • Naming its own responsable sanitario with a valid cédula profesional.
  • Maintaining NOM-024-SSA3-2012 certification for its Sistema de Información de Registro Electrónico para la Salud (SIRES) where applicable.
  • Issuing legally compliant electronic prescriptions (recetas electrónicas) including the prescribing physician’s name, cédula, issuing institution, and a verifiable digital signature or QR.
  • Obtaining patient informed consent before every teleconsultation.
  • Maintaining its own Aviso de Privacidad and LFPDPPP-compliant data handling.

TTL does not bill, prescribe, or hold the clinical record. We pass an informational handoff to the partner practice; the clinical relationship is theirs.

7. Data privacy (LFPDPPP)

Mexican personal-data protection is governed by the LFPDPPP. Sensitive health data requires express consent, which you grant when you sign up and use the platform. You retain ARCO rights at all times (Access, Rectification, Cancellation, Opposition), plus the right to limit use or revoke consent. Full details, contact channel, and INAI escalation are in our Aviso de Privacidad.

8. Cookie consent

A cookie consent banner is displayed on first visit. You can change your preferences at any time via the Cookie preferences link at the bottom of every page. Non-essential cookies do not load until you accept them. Essential cookies (session, security, language) are always active because the platform cannot function without them.

9. Medical disclaimer

Tomorrow Today Longevity (TTL) provides high-quality health and wellness information, powered by 25 AI experts, intended to support informed decision-making. This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult your physician (Consulta a tu médico) before making any health-related decisions or starting any new diet, supplement, exercise program, or treatment. Telehealth clinical services, when available, are provided by independently licensed telehealth medical practices — not by TTL. If you are experiencing a medical emergency, call 911 (or your local emergency number) immediately.

10. Compliance contact

Questions about Mexican compliance, advertising claims, data rights, or our telehealth partner’s credentials can be sent to:

Email: compliance@ttlongevity.com
Privacy / ARCO requests: privacy@ttlongevity.com
Toll-free (US & Mexico): +1 (877) 607-8469

If you believe your rights have been violated, you may file a complaint with the Instituto Nacional de Transparencia, Acceso a la Información y Protección de Datos Personales (INAI): www.inai.org.mx.

Built to be honest.

Our Mexico commitments are documented, public, and reviewable. If something on this page is unclear, write to compliance@ttlongevity.com — we’ll get back to you.

Start free intake → How it works